Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
expected
2
×
medicines
2
×
administration
ago
approval
australia's
biotechs
considering
data
devices
digital
diseases
drug
dyne
early
easier
experimental
eyes
genetic
goods
having
humans
ipo
ipos
long
make
medical
muscle
rare
reach
therapeutic
therapeutics
tick
transformation
undergo
worked
Language
unset
Current search:
expected
×
medicines
×
@zdnet.com
3 years ago
Australia's Therapeutic Goods Administration to undergo a AU$12m digital transformation
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
